Sleep Apnea Research Study
The University of Miami is conducting the PRAISE study to develop culturally tailored web-based intervention materials about sleep apnea and sleep health.
Fast Facts

Ages 55-85

Identify as Black or African American

Diagnosed with Obstructive Sleep Apnea

Compensation Provided

Conducted in Miami, FL
Study Background
This study is to see how effective our Personalized obstructive sleep apnea (OSA) Treatment Adherence Model (PRAISE) is in helping you stick to your physician recommended OSA treatment plan (Positive Airway Pressure or PAP).
People with OSA may experience impairment in memory, executive function (the ability to complete tasks and interact with others), attention, and vigilance (alertness). They also show increased levels of Alzheimer’s Disease (AD) biomarkers, which are substances in our body that when are present in large amounts, may indicate the presence of a disease.
Fortunately, OSA treatment has shown to reduce the levels of these AD biomarkers and improve all the cognitive functions mentioned earlier. Unfortunately, not enough is known about how OSA treatment affects Black people. Black people experience OSA and AD at much greater rates than other groups. Black people may not experience the benefits of OSA treatment due to a poor access to adequate OSA care or having greater difficulty sticking to their treatment plan, both of which makes managing the condition difficult.
Participants will complete a home-based 6 month study and attend two in-person visits at the University of Miami Hospital Campus.
Join our compensated study!
Study Background
This study is to see how effective our Personalized obstructive sleep apnea (OSA) Treatment Adherence Model (PRAISE) is in helping you stick to your physician recommended OSA treatment plan (Positive Airway Pressure or PAP).
People with OSA may experience impairment in memory, executive function (the ability to complete tasks and interact with others), attention, and vigilance (alertness). They also show increased levels of Alzheimer’s Disease (AD) biomarkers, which are substances in our body that when are present in large amounts, may indicate the presence of a disease.
Fortunately, OSA treatment has shown to reduce the levels of these AD biomarkers and improve all the cognitive functions mentioned earlier. Unfortunately, not enough is known about how OSA treatment affects Black people. Black people experience OSA and AD at much greater rates than other groups. Black people may not experience the benefits of OSA treatment due to a poor access to adequate OSA care or having greater difficulty sticking to their treatment plan, both of which makes managing the condition difficult.
Participants will complete a home-based 6 month study and attend two in-person visits at the University of Miami Hospital Campus.
Join our compensated study!
Additional Information
The purpose of this study is to see how effective our Personalized obstructive sleep apnea (OSA) Treatment Adherence Model called PRAISE is in helping participants stick to their physician recommended OSA treatment plan (Positive Airway Pressure or PAP).
You may qualify for this study if you meet the following criteria.
Inclusion Criteria:
- Ages 55-85
- Identify as Black or African American
- Diagnosed with Obstructive Sleep Apnea (OSA)
This study involves being exposed to OSA care videos throughout your 6-month participation in the study. We have a 2-month and 6-month follow-up where we will be measuring progress on your treatment plan and clinical exams. You will be expected to engage with the study materials between those follow-up periods. For both study arms, we expect that you will engage with the study materials while undergoing doctors’ recommended care such as PAP treatment. We would like to stress that access to your PAP treatment is not dependent on you participating in this study.
We will send you messages instructing you to watch the OSA care videos and answer online REDCap surveys respective to the study arm you were randomly assigned to. You will receive no more than 3 messages per day and may receive up to 10 messages per week.
Compensation is provided up to $150 for your participation.
There is no cost for you to participate in our research study.